z-logo
open-access-imgOpen Access
Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock
Author(s) -
Jin Joo Kim,
Young Jun Park,
Ki Yoon Moon,
Jin Hyeong Park,
Yong Ki Jeong,
Eun Young Kim
Publication year - 2019
Publication title -
world journal of gastrointestinal surgery
Language(s) - English
Resource type - Journals
ISSN - 1948-9366
DOI - 10.4240/wjgs.v11.i12.422
Subject(s) - hemoperfusion , medicine , septic shock , sofa score , intensive care unit , propensity score matching , polymyxin b , peritonitis , surgery , anesthesia , sepsis , antibiotics , hemodialysis , microbiology and biotechnology , biology
Polymyxin B hemoperfusion (PMX-HP) has been used as a treatment for intra-abdominal septic shock by absorbing and removing endotoxins of gram-negative bacilli.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here